Modern Management of Diabetes in Cardiology: Impact of SGLT2 Inhibition on CV Outcomes and Heart Failure
Meeting report with video, highlights and slides of PACE-CME symposium held at ESC 2017 in Barcelona, more items to follow...
1-3 of 3
- Modern Management of Diabetes in Cardiology: Impact of SGLT2 Inhibition on CV Outcomes and Heart FailureHeart failure & Diabetes: Time for a more unified approach
Stefan D. Anker MD
- Modern Management of Diabetes in Cardiology: Impact of SGLT2 Inhibition on CV Outcomes and Heart FailureSGLT2 inhibition in cardiology: What a cardiologist needs to know
Naveed Sattar, MD
- Modern Management of Diabetes in Cardiology: Impact of SGLT2 Inhibition on CV Outcomes and Heart FailureManagement of CV Risk & T2DM: Implications of novel outcome trials
John E Deanfield, MD
